Memorial Sloan-Kettering Cancer Center

Home/Tag: Memorial Sloan-Kettering Cancer Center

Global GIST Advocates Convene at LRG Headquarters

The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared [...]

By |2019-09-24T11:24:53-04:00December 28th, 2017|Advocacy, Global, News, Newsletter|

Ignyta Announces Results for Potential New Cancer Treatment

Dr. Alexander Drilon of Memorial Sloan Kettering Cancer Center recently reported at AACR on a potential new cancer treatment, Entrectinib, a receptor tyrosine kinase (RTK) inhibitor developed to target tumors carrying NTRK1, NTRK2, NTRK3, [...]

By |2020-02-21T15:04:32-05:00July 12th, 2016|Clinical Trials, News, Research|

Memorial Sloan Kettering Cancer Center Announces Innovative Basket Study

Memorial Sloan Kettering Cancer Center (MSKCC) recently announced results from a "basket study," an innovative clinical trial design that studies response to drugs based on specific mutations in patients' tumors rather than where the cancer originated.The [...]

By |2018-11-02T14:54:14-04:00August 26th, 2015|Clinical Trials, News, Research|
Go to Top